(secondQuint)Calcium Dobesilate Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome.

 Two hundred and twenty women at risk of ovarian hyperstimulation syndrome during ICSI cycles will be randomly scheduled into two equal groups.

 In group A, (Calcium Dobesilate group), 1 cap / 8 hs Doxium ( 500mg) will be given at day of HCG injection and for 21 days; while in group B (Cabergoline group), 1 tab/day Cabergoline( 0.

5 mg) will be given at day of HCG injection and for 8 days.

.

 Calcium Dobesilate Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome@highlight

The purpose of this study is to compare the effect of oral Calcium Dobesilate to oral Cabergoline in the prevention of ovarian hyperstimulation syndrome (OHSS) in high-risk women underwent intracytoplasmic sperm injection (ICSI).

